As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats, including to consider voluntary vaccination for those now at exposure risk.
“At this critical juncture, decisions about vaccine development, stockpiling, and deployment will shape our ability to respond to immediate and future pandemic risks,” write Jesse Goodman, MD, PhD; Rick A. Bright, PhD; and Nicole Lurie, MD, MSPH, in a JAMA Viewpoint published Sept. 4.
The current outbreak of H5N1 in North America has infected poultry, cows, wild birds, and marine and terrestrial mammals, along with at least 13 humans, primarily on dairy and poultry farms. No human-to-human transmission has been reported.
It is highly concerning that this H5N1 strain, compared with prior ones, has had unprecedented spread among mammals. Although human cases have so far been relatively mild, the threat of a pandemic is real, given the virus’s widespread and continued presence close to humans and its potential to reassort with human influenza viruses or mutate to acquire the ability to transmit among humans.”
Jesse Goodman, MD, PhD, Professor, Georgetown University
Goodman is a professor of medicine at Georgetown University School of Medicine and former FDA Chief Scientist; Bright is a principal with Bright Global Health and former Deputy Assistant Secretary for Preparedness and Response and the Director of the Biomedical Advanced Research and Development Authority (BARDA); and Lurie is executive director for Preparedness and Response at the Coalition for Epidemic Preparedness Innovations and Director of CEPI-US and former Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.
Focusing on vaccines, Goodman and his colleagues outline short, medium and long-term actions to combat the H5N1 risk: protect exposed individuals and reduce pandemic risk; refresh vaccine stockpiles and enhance capacity; lay the groundwork for mitigating future threats.
Short term
The authors note that the U.S. government is readying 4.8 million doses of stockpiled H5N8 vaccine, which is expected to offer cross-protection against current H5N1 strains.
As a short term consideration, the writers say, “Provided adequate supporting data and regulatory review, stockpiled vaccine(s) should be offered voluntarily to individuals at exposure risk.” Those at risk include farm workers with closure contact to animals.
Medium term
In the medium term, the authors stress the importance of ensuring that vaccine stockpiles are refreshed with doses well matched to circulating viruses. The goal is to ensure that at least 20 million individuals, particularly critical workforce members, can be rapidly immunized in the event of a pandemic.
In addition, the public health trio call for taking steps now to ready and enhance global pandemic influenza vaccine development and production capacity, including evaluating the potential of mRNA vaccines, which offer faster and more scalable manufacturing processes.
Long term
Looking further ahead, Goodman and his colleagues advocate for the exploration of pre-pandemic immunization strategies. This could involve vaccinating high-risk groups during interpandemic periods to build population immunity against potential pandemic strains, a strategy that, while unproven, could significantly mitigate the impact of future pandemics.
Finally, the authors call on elected officials, governments, global partners and the private sector to address H5N1 and other pandemic influenza threats through a comprehensive strategy for human and animal health encompassing pandemic vaccines as well as diagnostics, therapies, and non-pharmaceutical interventions. They note that the convergence of health and agricultural concerns, including protecting workers, farm animals, and the economy, presents an opportunity to transcend divides.
They conclude, “The time for decisive action is not when a pandemic strikes, but today, while we have the opportunity.”
Goodman, J. L., et al. (2024). H5 Influenza Vaccines—Moving Forward Against Pandemic Threats. JAMA. doi.org/doi:10.1001/jama.2024.17488
News
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]
The Future of Rare Disease Treatment with Precision Medicine
Understanding rare diseases Rare diseases affect less than 5 people out of 10,000. However, this still amounts to about 7% of the world’s population, with over 10,000 such conditions. Almost all are genetic in [...]
Doctors issue warning for upcoming ‘tripledemic
The term ‘tripledemic’ has hit headlines this week as the NHS begins its Covid and fluvaccine roll-out for vulnerable adults. As the cold weather sets in, many of us have experienced a decline in health, and this may [...]
The FDA approved a gel that can stop bleeding from wounds in seconds
Aug 15 (Reuters) - The U.S. Food and Drug Administration has cleared Cresilon's gel to quickly control bleeding, the privately held company said on Thursday, potentially giving emergency medical technicians and combat medics a [...]
High levels of microplastics found in prostate tumors, possibly linked to take-out food
The presence of microplastics in prostate tumors points to potential health risks, and researchers are calling for urgent studies to explore how take-out food may be driving this exposure. In a recent study published [...]
AI outperforms radiologists in brain tumor diagnosis
As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct diagnosis is crucial to ensure [...]
Breakthrough Study Reveals Molecular Clues to Dementia Origins
Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified “molecular markers” linked to degeneration—detectable changes in cells and their gene-regulating networks—that are common across several types [...]
Better than blood tests? Nanoparticle potential found for assessing kidneys
In a study published July 29 in Advanced Materials, University of Texas at Dallas researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney [...]
Greener nanomaterials could transform how our everyday stuff is made
Tiny nanoparticles are at the forefront of materials science—with special properties that make them great at absorbing light in solar panels, cleaning wastewater, and delivering drugs precisely. Some nanoparticles take the form of sheets or fibers. But nanomaterials all [...]
AI could predict breast cancer risk via ‘zombie cells’
Women worldwide could see better treatment with new AI technology, which enables better detection of damaged cells and more precisely predicts the risk of getting breast cancer, shows new research from the [...]
Through the eyes of a cat – biomimicry of feline eyes may revolutionize robotic vision
In a recent study published in the journal Science Advances, researchers leveraged crucial aspects of feline eyes, particularly their tapetum lucidum and vertically elongated pupils (VP), to develop a monocular artificial vision system capable of [...]
New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials
A study from TUM demonstrates a promising therapeutic approach. Researchers at the Technical University of Munich (TUM) have made promising advances in preventing Alzheimer’s by developing a new therapeutic strategy. Their approach focuses on targeting the amyloid beta [...]
Rewriting Cancer’s Blueprint: New Study Challenges Old Theories
A new study argues for a revised clonal evolution model of cancer, incorporating genetic and non-genetic factors to improve understanding and treatment. Like all living organisms, cancer cells are driven by the fundamental need [...]
Microplastics Everywhere: Experts Demand Worldwide Treaty Before It’s Too Late
A new report calls for global action on plastic pollution, urging reductions in plastic production and microplastic emissions. Researchers stress the importance of addressing plastic pollution through both scientific and social science perspectives. A [...]
Blood tests could soon predict your risk of Alzheimer’s
Scientists are closing in on biomarkers that reflect the progression of Alzheimer’s disease and could improve treatments. Like many Alzheimer’s researchers, neurologist Randall Bateman is not prone to effusiveness, having endured disappointments in his [...]
